ATE367389T1 - Benzisoxazolderivate mit d4-antagonistischer wirkung - Google Patents

Benzisoxazolderivate mit d4-antagonistischer wirkung

Info

Publication number
ATE367389T1
ATE367389T1 AT99914450T AT99914450T ATE367389T1 AT E367389 T1 ATE367389 T1 AT E367389T1 AT 99914450 T AT99914450 T AT 99914450T AT 99914450 T AT99914450 T AT 99914450T AT E367389 T1 ATE367389 T1 AT E367389T1
Authority
AT
Austria
Prior art keywords
amino
sulfonyl
group
dialkyl
alkoxy
Prior art date
Application number
AT99914450T
Other languages
English (en)
Inventor
Hartog Jacobus A Den
Gerben Visser
Steen Bartholomeus Van
Martinus Tulp
Eric Ronken
Cornelis Kruse
Josephus H Lange
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of ATE367389T1 publication Critical patent/ATE367389T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT99914450T 1998-02-09 1999-02-05 Benzisoxazolderivate mit d4-antagonistischer wirkung ATE367389T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200400 1998-02-09

Publications (1)

Publication Number Publication Date
ATE367389T1 true ATE367389T1 (de) 2007-08-15

Family

ID=8233376

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99914450T ATE367389T1 (de) 1998-02-09 1999-02-05 Benzisoxazolderivate mit d4-antagonistischer wirkung

Country Status (11)

Country Link
US (1) US6335326B1 (de)
EP (1) EP1054885B1 (de)
JP (1) JP4627882B2 (de)
AT (1) ATE367389T1 (de)
AU (1) AU3327399A (de)
CA (1) CA2320120C (de)
DE (1) DE69936572T2 (de)
DK (1) DK1054885T3 (de)
ES (1) ES2291023T3 (de)
PT (1) PT1054885E (de)
WO (1) WO1999040067A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE367389T1 (de) * 1998-02-09 2007-08-15 Duphar Int Res Benzisoxazolderivate mit d4-antagonistischer wirkung
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
ES2209995T3 (es) * 1999-09-14 2004-07-01 Aventis Pharmaceuticals Inc. Derivados de propilo sustituidos con tienoisoxazolil- y tienopirrazolil-fenoxi, utiles en calidad de antagonistas d4.
HUP0202706A3 (en) * 1999-09-14 2004-12-28 Aventis Pharmaceuticals Inc Br Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing them
PT1216249E (pt) * 1999-09-14 2004-04-30 Aventis Pharma Inc Derivados de etilicos e propilicos insubstituidos de tienoisoxazol-fenoxi uteis como antagonistas d4
US6747029B2 (en) 2001-03-12 2004-06-08 The Mclean Hospital Corporation Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder
WO2006090224A1 (en) * 2005-02-25 2006-08-31 Pfizer Japan Inc. Benzisoxazole derivatives
AU2008280187B2 (en) * 2007-07-26 2013-05-16 F. Hoffmann-La Roche Ag Dual modulators of 5-HT2A and D3 receptors
US8877778B2 (en) 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
CA2116117A1 (en) * 1991-08-22 1993-03-04 Hiroyuki Sueoka Benzisoxazole compound and use thereof
JPH0641125A (ja) * 1992-03-26 1994-02-15 Yoshitomi Pharmaceut Ind Ltd ベンゾイソオキサゾール化合物およびその用途
DK60593D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
FR2749304B1 (fr) * 1996-06-04 1998-06-26 Adir Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
ATE367389T1 (de) * 1998-02-09 2007-08-15 Duphar Int Res Benzisoxazolderivate mit d4-antagonistischer wirkung

Also Published As

Publication number Publication date
DE69936572D1 (de) 2007-08-30
CA2320120A1 (en) 1999-08-12
DK1054885T3 (da) 2007-10-15
JP2002502842A (ja) 2002-01-29
ES2291023T3 (es) 2008-02-16
EP1054885A2 (de) 2000-11-29
US6335326B1 (en) 2002-01-01
WO1999040067A2 (en) 1999-08-12
EP1054885B1 (de) 2007-07-18
PT1054885E (pt) 2007-10-03
CA2320120C (en) 2009-08-11
WO1999040067A3 (en) 1999-11-25
AU3327399A (en) 1999-08-23
DE69936572T2 (de) 2008-06-19
JP4627882B2 (ja) 2011-02-09

Similar Documents

Publication Publication Date Title
DK0858461T3 (da) Kondenserede tropanderivater som neurotransmittergenoptagelsesinhibitorer
DK1054885T3 (da) Benzisoxasolderivater med D4-antagonistisk virkning
DK1221440T3 (da) Benzoheterocykliske derivater der er nyttige som vasopressin- eller oxytocinmodulatorer
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
NO20033385D0 (no) Fuserte heterocykliske forbindelser
NO952208D0 (no) Amin-derivater
TR199902724T2 (xx) Dopamine D3 resept�rleri mod�lat�rleri olarak tetrahidroisokuinolin t�revleri.
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
NO2012021I2 (no) Perampanel eller salter eller hydrater derav
EA199901062A1 (ru) Производные хинолин-4-карбоксамида как антагонисты рецепторов нк-2 и нк-3
AUPP150098A0 (en) Benzamide derivatives
NO305287B1 (no) AMPA antagonister
HUP9700955A2 (hu) Szubsztituált 2-naftoil-guanidin-származékok, előállításuk, valamint az e vegyületeket tartalmazó gyógyszerkészítmények
PE20001384A1 (es) Derivados de acetamida no peptidicos como antagonistas de receptor de nk1
ATE239702T1 (de) 2-aminochinolinderivate mit d4-agonistischer wirkung
DK0712406T3 (da) Kondenserende indolderivater som 5-HT4-receptorantagonister
ES2132748T3 (es) Herbicidas de carbamato.
ATE203533T1 (de) INDOLDERIVATE ALS PRODRUGS VON ß5-HT1-LIKEß REZEPTOR AGONISTEN
AR014847A1 (es) 4-amino-(etilamino)-oxindoles agonistas del autoreceptor de dopamina y una composicion farmaceutica que los comprende
ES8403899A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzamida.
MX9702028A (es) Antagonistas de bradiquinina heterociclicos, sustituidos con fluoroalquilo y fluoroalcoxi, procedimientos para su preparacion y su utilizacion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1054885

Country of ref document: EP